Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 48,768 shares at $97.20 ($4.8M) on 2019-08-14, disclosed to the SEC on 2019-08-16.
Open-market sale of $4.8M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.07 | 4,715 | $448K | 9.4% |
| 2 | $95.91 | 6,107 | $586K | 12.3% |
| 3 | $97.20 | 3,921 | $381K | 8.0% |
| 4 | $98.23 | 13,704 | $1.3M | 28.2% |
| 5 | $99.12 | 20,321 | $2.0M | 42.2% |
| Total | $97.92 avg | 48,768 |
| $4.8M |
| 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |